Phase 3 Readout~month

Phase 3 Topline: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of

Drug
human
Indication
Muscular Dystrophy, Duchenne; Neuromuscular Diseases; Nervous System Diseases

Other upcoming events for CAPR

PDUFA DatePDUFA Date: deramiocel

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of — CAPR Phase 3 Readout | BioSniper